![Ingrid Heinze-Krauss](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ingrid Heinze-Krauss
Plus aucun poste en cours
Profil
Dr. Ingrid Heinze-Krauss is Chief Technology Officer at Basilea Pharmaceutica AG.
Dr. Heinze-Krauss was previously employed as Head-Medicinal Chemistry by Roche Group.
She received her doctorate degree from the University of Freiburg.
Anciens postes connus de Ingrid Heinze-Krauss
| Sociétés | Poste | Fin |
|---|---|---|
| BASILEA PHARMACEUTICA AG | Directeur Technique/Scientifique/R&D | 01/02/2016 |
Roche Group
 Roche Group Real Estate DevelopmentFinance Manages real estate properties | Corporate Officer/Principal | - |
Formation de Ingrid Heinze-Krauss
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
28
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
University of Freiburg
 University of Freiburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Group
Roche Group Real Estate DevelopmentFinance Manages real estate properties | Finance |
Basilea Pharmaceutica AG
 Basilea Pharmaceutica AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
